Get the Stockscreener App
2.27
2.58%
-0.06
Anebulo Pharmaceuticals Inc stock is traded at $2.27, with a volume of 920.
It is down -2.58% in the last 24 hours and down -10.28% over the past month.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
See More
Previous Close:
$2.33
Open:
$2.37
24h Volume:
920
Relative Volume:
0.02
Market Cap:
$93.26M
Revenue:
-
Net Income/Loss:
$-7.92M
P/E Ratio:
-7.5667
EPS:
-0.3
Net Cash Flow:
$-7.05M
1W Performance:
-2.99%
1M Performance:
-10.28%
6M Performance:
+116.19%
1Y Performance:
+46.45%
1-Day Range:
$2.2613
$2.37
1-Week Range:
$2.2601
$2.41
52-Week Range:
$0.8001
$3.39
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
Name
Anebulo Pharmaceuticals Inc
Sector
Industry
Phone
737 203 5270
Address
C/O ANEBULO PHARMACEUTICALS, INC., LAKEWAY
Compare ANEB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals Inc
|
2.27 | 95.73M | 0 | -7.92M | -7.05M | -0.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Anebulo Pharmaceuticals Inc Stock (ANEB) Latest News
Can Anebulo Pharmaceuticals Inc. stock deliver strong Q4 earningsMarket Volume Summary & Safe Capital Growth Tips - Newser
Anebulo Pharmaceuticals (NASDAQ:ANEB) Trading 0.8% HigherStill a Buy? - MarketBeat
Anebulo Pharmaceuticals (ANEB) Stock Analysis Report | Financials & Insights - Benzinga
Will Anebulo Pharmaceuticals Inc. stock reach Wall Street targetsMarket Volume Report & Free Low Drawdown Momentum Trade Ideas - Newser
Why retail investors pile into Anebulo Pharmaceuticals Inc. stock - BỘ NỘI VỤ
What drives Anebulo Pharmaceuticals Inc stock priceTechnical Resistance Breaks & Exceptional Profit Growth Tips - earlytimes.in
Will Anebulo Pharmaceuticals Inc. stock deliver strong dividend growthPortfolio Return Report & Weekly High Momentum Picks - newser.com
Will Anebulo Pharmaceuticals Inc. stock outperform value stocksJuly 2025 Fed Impact & Real-Time Market Trend Scan - newser.com
Can Anebulo Pharmaceuticals Inc. stock double in next 5 yearsRate Hike & Risk Managed Investment Entry Signals - newser.com
Will Anebulo Pharmaceuticals Inc. continue its uptrend2025 Market Sentiment & Reliable Price Action Trade Plans - newser.com
Is it too late to sell Anebulo Pharmaceuticals Inc.Gap Up & Reliable Entry Point Trade Alerts - newser.com
Has Anebulo Pharmaceuticals Inc. found a price floorPortfolio Return Report & Long-Term Growth Plans - newser.com
Risk vs reward if holding onto Anebulo Pharmaceuticals Inc.July 2025 Technicals & Real-Time Volume Analysis Alerts - newser.com
How Anebulo Pharmaceuticals Inc. stock valuations compare to rivalsPortfolio Profit Report & Reliable Price Breakout Alerts - newser.com
Is Anebulo Pharmaceuticals Inc. stock supported by strong cash flows2025 Biggest Moves & Long-Term Investment Growth Plans - newser.com
Will Anebulo Pharmaceuticals Inc. stock beat EPS estimates2025 Big Picture & Free High Return Stock Watch Alerts - newser.com
Is Anebulo Pharmaceuticals Inc a good long term investmentEarnings Date Calendar & Outstanding Investment Trading - earlytimes.in
Is Anebulo Pharmaceuticals Inc. stock attractive for ETFsMarket Volume Report & Expert Curated Trade Setup Alerts - newser.com
Quantitative breakdown of Anebulo Pharmaceuticals Inc. recent moveJuly 2025 Pullbacks & Daily Volume Surge Trade Alerts - newser.com
Anebulo Pharmaceuticals Reports Q1 2026 Financial Results - MSN
[10-Q] Anebulo Pharmaceuticals, Inc. Quarterly Earnings Report | ANEB SEC FilingForm 10-Q - Stock Titan
Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2025 - MarketScreener
Anebulo Pharmaceuticals posts Q1 net loss - MarketScreener
[8-K] Anebulo Pharmaceuticals, Inc. Reports Material Event | ANEB SEC FilingForm 8-K - Stock Titan
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates - Business Wire
Is Anebulo Pharmaceuticals Inc. stock ready for a breakoutProfit Target & Daily Technical Stock Forecast Reports - newser.com
What is the fair value of Anebulo Pharmaceuticals Inc. stock nowJuly 2025 Short Interest & Growth Focused Entry Reports - newser.com
Is Anebulo Pharmaceuticals Inc. stock a buy for dividend growthJuly 2025 Analyst Calls & Weekly High Momentum Picks - newser.com
Anebulo Pharmaceuticals Inc Stock (ANEB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):